Recommendations for the diagnosis and management of Niemann–Pick disease type C: An updateMarc C. Patterson, Frits A. Wijburg, Christian J. Hendriksz et al.|Molecular Genetics and Metabolism|2012Cited by 478
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gary Cutter et al.|The Lancet Neurology|2020Cited by 104